Clinical note. Phase II study of 1-aminocyclopentanecarboxylic acid (NSC-1026) in patients with cancer.
作者信息
Aust J B, Andrews N C, Schroeder J M, Lawton R L
出版信息
Cancer Chemother Rep. 1970 Aug;54(4):237-41.
PMID:4946007
Abstract
摘要
相似文献
1
Clinical note. Phase II study of 1-aminocyclopentanecarboxylic acid (NSC-1026) in patients with cancer.临床记录。1-氨基环戊烷羧酸（NSC-1026）用于癌症患者的II期研究。
Cancer Chemother Rep. 1970 Aug;54(4):237-41.
2
Chemotherapy in prevention of the recurrence of resectable cancer.
Annu Rev Med. 1978;29:149-75. doi: 10.1146/annurev.me.29.020178.001053.
3
Phase II study of cis-diamminedichloroplatinum (NSC-119875) in advanced carcinoma of the large bowel.
Cancer Chemother Rep. 1973 Sep-Oct;57(3):357-9.
4
6-Mercaptopurine (NSC-755) given intermittently in high doses: phase II study.高剂量间歇给予6-巯基嘌呤（NSC-755）：II期研究。
Cancer Chemother Rep. 1970 Feb;54(1):31-4.
5
Phase II studies of homoharringtonine in patients with advanced malignant melanoma; sarcoma; and head and neck, breast, and colorectal carcinomas.
Cancer Treat Rep. 1986 Mar;70(3):375-9.
6
Further clinical studies of trimethylpurin-6-ylammonium chloride (NSC-51095) in malignant disease with special emphasis on cancer of urinary bladder.
Cancer Chemother Rep. 1970 Jun;54(3):181-5.
7
Daunorubicin treatment of adult solid tumors.
Cancer Treat Rep. 1981;65 Suppl 4:25-8.
8
Reversal of antileukemic action and toxicity of 1-aminocyclopentanecarboxylic acid in mice by L-valine.
Cancer Res. 1969 Mar;29(3):728-9.
9
Cis-diamminedichloroplatinum (II). A new anticancer drug.顺二氯二氨合铂（II）。一种新型抗癌药物。
Ann Intern Med. 1977 Jun;86(6):803-12. doi: 10.7326/0003-4819-86-6-803.
10
Cis-diamminedichloroplatinum (NSC-119875): a phase I study.
Cancer Chemother Rep. 1973 Nov-Dec;57(4):459-63.
Zotero 插件